Hendershot Investments Inc. Trims Position in MAXIMUS, Inc. (MMS)

Hendershot Investments Inc. lowered its position in shares of MAXIMUS, Inc. (NYSE:MMS) by 48.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 20,027 shares of the health services provider’s stock after selling 19,108 shares during the period. Hendershot Investments Inc.’s holdings in MAXIMUS were worth $1,434,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Koch Industries Inc. bought a new stake in MAXIMUS during the 2nd quarter worth $629,000. Public Employees Retirement System of Ohio grew its position in shares of MAXIMUS by 42.1% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 104,056 shares of the health services provider’s stock valued at $6,712,000 after buying an additional 30,804 shares during the last quarter. Shelton Capital Management bought a new stake in shares of MAXIMUS in the 2nd quarter valued at about $308,000. OxFORD Asset Management LLP grew its position in shares of MAXIMUS by 338.0% in the 3rd quarter. OxFORD Asset Management LLP now owns 33,885 shares of the health services provider’s stock valued at $2,186,000 after buying an additional 26,148 shares during the last quarter. Finally, Cornerstone Capital Management Holdings LLC. grew its position in shares of MAXIMUS by 798.2% in the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 172,286 shares of the health services provider’s stock valued at $11,110,000 after buying an additional 153,104 shares during the last quarter. Institutional investors and hedge funds own 94.92% of the company’s stock.

A number of research firms have commented on MMS. Canaccord Genuity reiterated a “buy” rating on shares of MAXIMUS in a research report on Wednesday, December 27th. Zacks Investment Research upgraded MAXIMUS from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $65.60.

MAXIMUS, Inc. (MMS) traded up $0.51 during midday trading on Monday, hitting $70.09. The company’s stock had a trading volume of 614,800 shares, compared to its average volume of 449,723. MAXIMUS, Inc. has a 1 year low of $51.74 and a 1 year high of $72.71. The company has a market cap of $4,565.42, a price-to-earnings ratio of 22.04, a PEG ratio of 2.63 and a beta of 1.34.

MAXIMUS (NYSE:MMS) last announced its quarterly earnings data on Thursday, November 9th. The health services provider reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.04. MAXIMUS had a return on equity of 23.97% and a net margin of 8.54%. equities analysts expect that MAXIMUS, Inc. will post 3.05 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be paid a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date of this dividend is Wednesday, February 14th. MAXIMUS’s dividend payout ratio is 5.66%.

In other news, Director Russell A. Beliveau sold 1,500 shares of the business’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $64.30, for a total value of $96,450.00. Following the transaction, the director now directly owns 40,329 shares of the company’s stock, valued at approximately $2,593,154.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Richard A. Montoni sold 30,000 shares of the business’s stock in a transaction dated Thursday, December 7th. The shares were sold at an average price of $69.25, for a total value of $2,077,500.00. The disclosure for this sale can be found here. Insiders sold a total of 71,417 shares of company stock worth $4,902,785 over the last three months. 3.10% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/01/22/hendershot-investments-inc-trims-position-in-maximus-inc-mms.html.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply